Additionally, higher serum adiponectin concentrations are associated with development of cancer and cancer-related deaths in T2DM patients- one more implication of ‘adiponectin paradox’ and this was reported just recently [220]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.